Ardelyx (ARDX) Net Margin (2013 - 2026)

Ardelyx's (ARDX) quarterly Net Margin came in at 39.81% in Q1 2026, up 1571.0% YoY from 2.38% in Q1 2025, and down 12146.16% on a QoQ basis from 0.33% in Q4 2025.

Ardelyx (ARDX) Net Margin (2013 - 2026) Analysis & Trends

Ardelyx (ARDX) has 12 years of Net Margin data on file, last reported at 39.81% in Q1 2026.

  • Quarterly Net Margin rose 1571.0% year-over-year to 39.81% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 18.1% (down 324.0% YoY) and the FY2025 annual result came in at 15.12%, down 339.0% from the prior year.
  • Net Margin retreated to 39.81% in Q1 2026, from 0.33% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 24.21% in Q4 2022 to a low of 5998.08% in Q1 2022.
  • A 5-year average of 476.72% and a median of 39.81% in 2026 frame the typical range for Net Margin.
  • Annual changes were most pronounced in 2022 — Net Margin slumped 549435 bps — and 2023, when it jumped 576259 bps.
  • Tracing ARDX's Net Margin over 5 years: stood at 24.21% in 2022, then plunged by 446 bps to 83.82% in 2023, then surged by 105 bps to 4.0% in 2024, then plunged by 108 bps to 0.33% in 2025, then plunged by 12146 bps to 39.81% in 2026.
  • The last three Net Margin figures came in at 39.81% (Q1 2026), 0.33% (Q4 2025), and 28.5% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 30.23%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 30.33%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 13.90%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 30.98%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 12.09%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 12.74%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -3.12%
10 Ardelyx 1.01 Bn 729.71 Mn 115.12 Mn -13.83%

Historic Data

Download Data
DateValue
Jun 30, 2026 -13.83%
Mar 31, 2026 -39.81%
Dec 31, 2025 -0.33%
Sep 30, 2025 -28.50%
Jun 30, 2025 -19.54%
Mar 31, 2025 -55.51%
Dec 31, 2024 4.00%
Sep 30, 2024 -0.82%
Jun 30, 2024 -22.47%
Mar 31, 2024 -57.62%
Dec 31, 2023 -83.82%
Sep 30, 2023 11.76%
Jun 30, 2023 -76.66%
Mar 31, 2023 -235.49%
Dec 31, 2022 24.21%
Sep 30, 2022 -459.15%
Jun 30, 2022 -1,066.43%
Mar 31, 2022 -5,998.08%
Dec 31, 2021 -3,521.28%
Sep 30, 2021 -3,715.86%